Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-04

Clinical Trial Update: Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant toremifene with melatonin or metformin in locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)
  • Toremifene (toremifene)
  • metformin (metformin)

Snippet

Sponsor: N.N. Petrov National Medical Research Center of Oncology | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN